PortfoliosLab logo
RMD vs. MCK
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between RMD and MCK is 0.42, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.


-0.50.00.51.0
Correlation: 0.4

Performance

RMD vs. MCK - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in ResMed Inc. (RMD) and McKesson Corporation (MCK). The values are adjusted to include any dividend payments, if applicable.

0.00%10,000.00%20,000.00%30,000.00%40,000.00%50,000.00%NovemberDecember2025FebruaryMarchApril
41,864.06%
3,801.60%
RMD
MCK

Key characteristics

Sharpe Ratio

RMD:

0.75

MCK:

1.15

Sortino Ratio

RMD:

1.35

MCK:

1.56

Omega Ratio

RMD:

1.19

MCK:

1.26

Calmar Ratio

RMD:

0.78

MCK:

1.31

Martin Ratio

RMD:

3.58

MCK:

3.22

Ulcer Index

RMD:

8.16%

MCK:

9.71%

Daily Std Dev

RMD:

38.77%

MCK:

27.32%

Max Drawdown

RMD:

-61.60%

MCK:

-82.83%

Current Drawdown

RMD:

-18.21%

MCK:

-3.06%

Fundamentals

Market Cap

RMD:

$34.68B

MCK:

$86.28B

EPS

RMD:

$8.92

MCK:

$21.81

PE Ratio

RMD:

26.47

MCK:

31.56

PEG Ratio

RMD:

1.39

MCK:

1.19

PS Ratio

RMD:

6.91

MCK:

0.25

PB Ratio

RMD:

6.00

MCK:

5.04

Total Revenue (TTM)

RMD:

$5.02B

MCK:

$268.23B

Gross Profit (TTM)

RMD:

$2.94B

MCK:

$9.49B

EBITDA (TTM)

RMD:

$1.65B

MCK:

$3.54B

Returns By Period

In the year-to-date period, RMD achieves a 3.38% return, which is significantly lower than MCK's 22.08% return. Over the past 10 years, RMD has outperformed MCK with an annualized return of 15.30%, while MCK has yielded a comparatively lower 12.68% annualized return.


RMD

YTD

3.38%

1M

6.31%

6M

-7.48%

1Y

29.77%

5Y*

8.88%

10Y*

15.30%

MCK

YTD

22.08%

1M

4.82%

6M

37.28%

1Y

29.31%

5Y*

38.85%

10Y*

12.68%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

RMD vs. MCK — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

RMD
The Risk-Adjusted Performance Rank of RMD is 7878
Overall Rank
The Sharpe Ratio Rank of RMD is 7979
Sharpe Ratio Rank
The Sortino Ratio Rank of RMD is 7575
Sortino Ratio Rank
The Omega Ratio Rank of RMD is 7676
Omega Ratio Rank
The Calmar Ratio Rank of RMD is 8080
Calmar Ratio Rank
The Martin Ratio Rank of RMD is 8282
Martin Ratio Rank

MCK
The Risk-Adjusted Performance Rank of MCK is 8484
Overall Rank
The Sharpe Ratio Rank of MCK is 8787
Sharpe Ratio Rank
The Sortino Ratio Rank of MCK is 7979
Sortino Ratio Rank
The Omega Ratio Rank of MCK is 8484
Omega Ratio Rank
The Calmar Ratio Rank of MCK is 8888
Calmar Ratio Rank
The Martin Ratio Rank of MCK is 8080
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

RMD vs. MCK - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for ResMed Inc. (RMD) and McKesson Corporation (MCK). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


The chart of Sharpe ratio for RMD, currently valued at 0.75, compared to the broader market-2.00-1.000.001.002.003.00
RMD: 0.75
MCK: 1.15
The chart of Sortino ratio for RMD, currently valued at 1.35, compared to the broader market-6.00-4.00-2.000.002.004.00
RMD: 1.35
MCK: 1.56
The chart of Omega ratio for RMD, currently valued at 1.19, compared to the broader market0.501.001.502.00
RMD: 1.19
MCK: 1.26
The chart of Calmar ratio for RMD, currently valued at 0.78, compared to the broader market0.001.002.003.004.005.00
RMD: 0.78
MCK: 1.31
The chart of Martin ratio for RMD, currently valued at 3.58, compared to the broader market-5.000.005.0010.0015.0020.00
RMD: 3.58
MCK: 3.22

The current RMD Sharpe Ratio is 0.75, which is lower than the MCK Sharpe Ratio of 1.15. The chart below compares the historical Sharpe Ratios of RMD and MCK, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio0.501.001.502.00NovemberDecember2025FebruaryMarchApril
0.75
1.15
RMD
MCK

Dividends

RMD vs. MCK - Dividend Comparison

RMD's dividend yield for the trailing twelve months is around 0.88%, more than MCK's 0.40% yield.


TTM20242023202220212020201920182017201620152014
RMD
ResMed Inc.
0.88%0.88%1.07%0.83%0.62%0.73%0.98%1.26%1.61%2.03%2.16%1.89%
MCK
McKesson Corporation
0.40%0.47%0.50%0.54%0.72%0.95%1.16%1.32%0.80%0.80%0.53%0.46%

Drawdowns

RMD vs. MCK - Drawdown Comparison

The maximum RMD drawdown since its inception was -61.60%, smaller than the maximum MCK drawdown of -82.83%. Use the drawdown chart below to compare losses from any high point for RMD and MCK. For additional features, visit the drawdowns tool.


-30.00%-25.00%-20.00%-15.00%-10.00%-5.00%0.00%NovemberDecember2025FebruaryMarchApril
-18.21%
-3.06%
RMD
MCK

Volatility

RMD vs. MCK - Volatility Comparison

ResMed Inc. (RMD) has a higher volatility of 14.81% compared to McKesson Corporation (MCK) at 8.93%. This indicates that RMD's price experiences larger fluctuations and is considered to be riskier than MCK based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


4.00%6.00%8.00%10.00%12.00%14.00%NovemberDecember2025FebruaryMarchApril
14.81%
8.93%
RMD
MCK

Financials

RMD vs. MCK - Financials Comparison

This section allows you to compare key financial metrics between ResMed Inc. and McKesson Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items